Panacea Life Sciences Holdings, Inc. Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) of $1.41 million for the 3-month period ending 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Income Statement › Other Income
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2021-05-27
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for the quarter ending 2021-03-31 was $1.41M.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for the quarter ending 2020-12-31 was $911.21K.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for the quarter ending 2020-09-30 was -$41.07K.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for the quarter ending 2020-06-30 was -$249.98K.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for fiscal 2020 was $513.67K, a 42.10% decline from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for fiscal 2019 was $887.12K, a 104.47% increase from fiscal 2018.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for fiscal 2018 was $433.86K, a 703.44% increase from fiscal 2017.
- Panacea Life Sciences Holdings, Inc. fair value, net derivative asset (liability), recurring basis, still held, unrealized gain (loss) for fiscal 2017 was $54.00K.
| Period end | Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month | Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month | Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-03-31 | $1.41M 10-Q/A · filed 2021-05-27 | $2.32M derived: sum of 2 quarters · filed 2021-05-27 | $2.28M derived: sum of 3 quarters · filed 2021-05-27 | $2.03M derived: sum of 4 quarters · filed 2021-05-27 | |
| 2020-12-31 | $911.21K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $870.14K derived: sum of 2 quarters · filed 2021-04-23 | $620.16K derived: sum of 3 quarters · filed 2021-04-23 | $513.67K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | -$41.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | -$291.05K derived: sum of 2 quarters · filed 2020-11-18 | -$397.54K 10-Q · filed 2020-11-18 | -$406.42K derived: sum of 4 quarters · filed 2021-04-23 | |
| 2020-06-30 | -$249.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | -$356.47K 10-Q · filed 2020-08-19 | -$365.35K derived: sum of 3 quarters · filed 2021-04-23 | -$365.35K derived: sum of 4 quarters · filed 2021-04-23 | |
| 2020-03-31 | -$106.49K 10-Q · filed 2020-06-29 | -$115.37K derived: sum of 2 quarters · filed 2021-04-23 | -$115.37K derived: sum of 3 quarters · filed 2021-04-23 | -$115.37K derived: sum of 4 quarters · filed 2021-04-23 | |
| 2019-12-31 | -$8.88K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | -$8.88K derived: sum of 2 quarters · filed 2021-04-23 | -$8.88K derived: sum of 3 quarters · filed 2021-04-23 | $887.12K 10-K/A · filed 2021-04-23 | $1.08M 10-K · filed 2020-05-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $896.00K 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $896.00K 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | $896.00K 10-Q · filed 2019-05-20 | ||||
| 2018-12-31 | $433.86K 10-K · filed 2020-05-22 | ||||
| 2017-12-31 | $54.00K 10-K · filed 2019-03-29 |